Role of tumor necrosis factor α in hyperthermia-induced apoptosis of human leukemia cells

Cancer Research

Volumn 59, Issue 14, 1999, Pages 3404-3410

  Katschinski, Dörthe M ^a   Robins, H Ian ^b   Schad, Martina ^a   Frede, Stilla ^c   Fandrey, Joachim ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF WISCONSIN   (United States)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; HEAT TREATMENT; HUMAN; HUMAN CELL; HYPERTHERMIA; MYELOID LEUKEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL CYCLE; CELL DIFFERENTIATION; DIMETHYLFORMAMIDE; FEVER; GENE EXPRESSION REGULATION, LEUKEMIC; GENES, BCL-2; HEAT; HUMANS; HYPERTHERMIA, INDUCED; LEUKEMIA, MYELOMONOCYTIC, ACUTE; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PYRROLIDINES; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; THIOCARBAMATES; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033565214     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Barinaga, M. Death by dozens of cuts. Science (Washington DC), 280: 32-34, 1998.
2. Yin, X. M., Oltvai, Z. N., and Korsmeyer, S. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature (Lond.), 369: 321-323, 1994.
3. Schmaltz, C., Harrigan Hardenbergh, P., Wells, A., and Fisher, D. E. Regulation of proliferation-survival decisions during tumor cell hypoxia. Mol. Cell. Biol., 18: 2845-2854, 1998.
4. Takasu, T., Lyons, J. C., Park, H. J., and Song, C. W. Apoptosis and perturbation of cell cycle progression in an acidic environment after hyperthermia. Cancer Res., 58: 2504-2508, 1998.
5. Vaupel, P., Kallinowski, F., and Okunieff, P. Blood flow oxygen and nutrient supply and metabolic environment of human tumors: a review. Cancer Res., 49: 6449-6465, 1989.
6. Robins, H. I., Cohen, J. D., and Neville, A. J. Whole Body Hyperthermia Biological and Clinical Aspects. Berlin: Springer Verlag, 1992.
7. Robins, H. I., Steeves, R. A., Martin, P. A., Miller, K., Clark, A. W., and Dennis, W. H. Differential sensitivity of AKR murine leukemia and normal bone marrow cells to hyperthermia. Cancer Res., 43: 4951-4955, 1983.
8. Robins, H. I., Dennis, W. H., Martin, P. A., Sondel, P. M., Yatvin, M. B., and Steeves, R. A. Potentiation of differential hyperthermic sensitivity of AKR leukemia and normal bone marrow cells by lidocaine or thiopental. Cancer (Phila.), 54: 2831-2835, 1984.
9. Robins, H. I., Dennis, W. H., Steeves, R. A., and Sondel, R. A. A proposal for the addition of hyperthermia to treatment regimens for acute and chronic leukemia. J. Clin. Oncol., 2: 1050-1056, 1984.
10. Larocca, L. M., Ranelletti, F. O., Maggiano, N., Rutela, S., La Barbera, E. O., Rumi, C., Serra, F., Voso, M. T., Piantelli, M., Teofili, L., and Leone, G. Differential sensitivity of leukemic and normal hematopoietic progenitors to the killing effect of hyperthermia and quercetin used in combination: role of heat-shock protein-70. Int. J. Cancer, 73: 75-83, 1997.
11. Gorczyca, W., Gong, J., Ardelt, B., Traganos, F., and Darzynkiewicz, Z. The cell cycle-related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents. Cancer Res., 53: 3186-3192, 1993.
12. Loetscher, H., Stueber, D., Banner, D., Mackay, F., and Lesslauer, W. Human tumor necrosis factor-α (TNF-α) mutants with exclusive specificity for the 55-kDa or 75-kDa TNF receptors. J. Biol. Chem. 268: 26350-26357, 1993.
13. Van Ostade, X., Vandenabeele, P., Everaerdt, B., Loetscher, H., Gentz, R., Brockhaus, M., Lesslauer, W., Tavernier, J., Brouckaert, P., and Fiers, W. Human TNF mutants with selective activity on the p55 receptor. Nature (Lond.) 361: 266-259, 1993.
14. Karnovsky, M. J. Cytochemistry and reactive oxygen species a retrospective. Histochemistry, 102: 15-27, 1994.
15. Frede, S., Deetjen, C., Schobersberger, W., and Hoffmann, G. Granulocyte-colony stimulating factor inhibits TNFa production in a human hepatoma cell line. Pfluegers Arch., 436: 233-237, 1998.
16. Fandrey, J., and Bunn, H. F. In vivo and in vitro regulation of erythropoietin mRNA measurement by competitive polymerase chain reaction. Blood, 81: 617-623, 1993.
17. Frede, S., Fandrey, J., and Jelkmann, W. Interleukin 1β and phorbol ester induce tumor necrosis factor α production in a hepatic cell line (HepG2). Pfluegers Arch., 431: 923-927, 1996.
18. Schreck, R., Meier, B., Mannel, D. N., Droge, W., and Baeuerle, P. A. Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J. Exp. Med., 175: 1181-1194, 1992.
19. Jewett, A., Cavalcanti, M., and Bonavida, B. Pivotal role of endogenous TNF-α in the induction of functional inactivation and apoptosis in NK cells. J. Immunol., 159: 4815-4822, 1997.
20. Ross, M. E., and Caliguri, M. A. Cytokine-induced apoptosis of human natural killer cells identifies a novel mechanism to regulate the innate immune response. Blood, 89: 910-918, 1997.
21. Friesen, C., Herr, I., Krammer, P. H., and Debatin, K. M. 1996. Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat. Med., 2: 574-577, 1996.
22. Giri, D. K., and Aggarwal, B. B. Constitutive activation of NF-κB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. J. Biol. Chem., 273: 14008-14014, 1998.
23. Tartaglia, L. A., Ayres, T. M., Wong, G. H. W., and Goeddel, D. V. A novel domain within the 60 kD TNF receptor signals cell death. Cell, 74: 845-853, 1993.
24. Vandenabeele, P., Declercq, W., Beyaert, R., and Fiers, W. Two tumor necrosis factor receptors: structure and function. Trends Cell Biol., 5: 392-395, 1995.
25. Chainy, G. B. N., Singh, S., Raju, U., and Aggarwal, B. B. Differential activation of the nuclear factor-κB by TNF muteins specific for the p60 and p80 TNF receptors. J. Immunol., 157: 2410-2417, 1996.
26. Haridas, V., Damay, B. G., Natarajan, K., Heller, R., and Aggarwal, B. B. Overexpression of the p80 receptor leads to TNF-dependent apoptosis nuclear factor-κB activation and c-jun kinase activation. J. Immunol., 160: 3152-3162, 1998.
27. Hug, H., Strand, S., Grambihler, A., Galle, J., Hack, V., Stremmel, W., Krammer, P, H, and Galle, P. R. Reactive oxygen species intermediates are involved in the induction of CD95 ligand mRNA expression by cytostatic drugs in hepatoma cells. J. Biol. Chem., 272: 28191-28193, 1997.
28. Hiroaka, W., Vazquez, N., Nieves-Neira, W., Chanock, S. J., and Pommier, Y. Role of oxygen radicals generated by NADPH oxidase in apoptosis induced in human leukemia cells. J. Clin. Investig., 102: 1961-1968, 1998.
29. Shen, Q., Chada, S., Whitney, C., Newburger, P. E. Regulation of the human cellular glutathione peroxidase gene during in vitro myeloid and monocytic differentiation. Blood, 84: 3902-3908, 1994.